Every year, leading prostate cancer clinicians, scientists, and experts gather at conferences around the world to share the latest research, treatment advances, and ideas that may shape care in the future. Explore key findings and clinician perspectives translated into information relevant to patients and families.
Learn how enzalutamide plus Radium-223 improved outcomes in mCRPC with bone metastases and why bone-protective therapy is important.
